An S. De Vriese

13.5k total citations · 1 hit paper
173 papers, 8.9k citations indexed

About

An S. De Vriese is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, An S. De Vriese has authored 173 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Nephrology, 40 papers in Pulmonary and Respiratory Medicine and 28 papers in Surgery. Recurrent topics in An S. De Vriese's work include Dialysis and Renal Disease Management (39 papers), Chronic Kidney Disease and Diabetes (24 papers) and Renal Diseases and Glomerulopathies (21 papers). An S. De Vriese is often cited by papers focused on Dialysis and Renal Disease Management (39 papers), Chronic Kidney Disease and Diabetes (24 papers) and Renal Diseases and Glomerulopathies (21 papers). An S. De Vriese collaborates with scholars based in Belgium, United States and Netherlands. An S. De Vriese's co-authors include Norbert Lameire, Allan Flyvbjerg, Bieke F. Schrijvers, Johan Van de Voorde, Fernando C. Fervenza, Siska Mortier, Ronald G. Tilton, Stefaan J. Vandecasteele, Tony J. Verbeuren and Sanjeev Sethi and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

An S. De Vriese

165 papers receiving 8.6k citations

Hit Papers

Endothelial dysfunction i... 2000 2026 2008 2017 2000 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
An S. De Vriese Belgium 50 3.5k 2.0k 1.4k 1.3k 1.3k 173 8.9k
Dominic S. Raj United States 52 4.2k 1.2× 2.2k 1.1× 1.4k 1.1× 1.6k 1.2× 971 0.8× 165 9.0k
Paola Fioretto Italy 53 4.5k 1.3× 1.9k 0.9× 2.0k 1.5× 1.9k 1.5× 870 0.7× 201 10.2k
Sydney Tang Hong Kong 51 4.3k 1.2× 2.0k 1.0× 1.1k 0.8× 563 0.4× 944 0.7× 314 9.4k
Gabriel Choukroun France 48 3.5k 1.0× 2.1k 1.0× 978 0.7× 1.3k 1.0× 1.1k 0.9× 228 8.4k
Yoshinari Yasuda Japan 40 4.1k 1.2× 1.8k 0.9× 1.6k 1.2× 2.3k 1.7× 1.6k 1.3× 152 10.6k
Jan T. Kielstein Germany 55 3.6k 1.0× 1.5k 0.7× 1.4k 1.1× 2.6k 2.0× 1.2k 1.0× 278 10.2k
Samir M. Parikh United States 47 3.1k 0.9× 3.4k 1.7× 1.6k 1.2× 1.6k 1.2× 1.6k 1.3× 127 10.6k
Günter Wolf Germany 52 3.7k 1.0× 3.5k 1.7× 1.4k 1.0× 1.9k 1.5× 1.1k 0.9× 359 12.3k
Tae‐Hyun Yoo South Korea 45 4.4k 1.2× 1.6k 0.8× 1.1k 0.8× 1.1k 0.8× 1.3k 1.0× 371 8.6k
Masaru Horio Japan 31 3.9k 1.1× 1.5k 0.7× 1.5k 1.1× 2.3k 1.7× 1.5k 1.2× 103 9.7k

Countries citing papers authored by An S. De Vriese

Since Specialization
Citations

This map shows the geographic impact of An S. De Vriese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An S. De Vriese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An S. De Vriese more than expected).

Fields of papers citing papers by An S. De Vriese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An S. De Vriese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An S. De Vriese. The network helps show where An S. De Vriese may publish in the future.

Co-authorship network of co-authors of An S. De Vriese

This figure shows the co-authorship network connecting the top 25 collaborators of An S. De Vriese. A scholar is included among the top collaborators of An S. De Vriese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An S. De Vriese. An S. De Vriese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tozzi, Matteo, Jan De Letter, Dainis Krieviņš, et al.. (2025). Endogenous tissue restoration in a hemodialysis conduit: Performance and safety after 1-year of follow-up. The Journal of Vascular Access. 959591151–959591151.
2.
Tozzi, Matteo, Jan De Letter, Dainis Krieviņš, et al.. (2024). First-in-human feasibility study of the aXess graft (aXess-FIH): 6-Month results. The Journal of Vascular Access. 26(2). 502–509. 4 indexed citations
3.
Vriese, An S. De, Sanjeev Sethi, & Fernando C. Fervenza. (2024). Lupus nephritis: redefining the treatment goals. Kidney International. 107(2). 198–211. 9 indexed citations
4.
Heine, Gunnar H., Rupert Bauersachs, Ingo Eitel, et al.. (2024). Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation. Clinical Kidney Journal. 17(10). sfae270–sfae270.
5.
Karoui, Khalil El, Fernando C. Fervenza, & An S. De Vriese. (2023). Treatment of IgA Nephropathy: A Rapidly Evolving Field. Journal of the American Society of Nephrology. 35(1). 103–116. 41 indexed citations
6.
Vriese, An S. De, Jens Van Praet, Marijke Reynders, et al.. (2021). Longevity and correlation with disease severity of the humoral and cellular response to SARS-CoV-2 infection in haemodialysis patients. Clinical Kidney Journal. 14(11). 2446–2448. 3 indexed citations
7.
Vriese, An S. De, Jack F.M. Wetzels, Richard J. Glassock, Sanjeev Sethi, & Fernando C. Fervenza. (2021). Therapeutic trials in adult FSGS: lessons learned and the road forward. Nature Reviews Nephrology. 17(9). 619–630. 63 indexed citations
8.
Bobart, Shane A., Shahrzad Tehranian, Sanjeev Sethi, et al.. (2021). A Target Antigen–Based Approach to the Classification of Membranous Nephropathy. Mayo Clinic Proceedings. 96(3). 577–591. 40 indexed citations
9.
Praet, Jens Van, Marijke Reynders, Dirk De Bacquer, et al.. (2021). Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study. Journal of the American Society of Nephrology. 32(12). 3208–3220. 62 indexed citations
10.
Vriese, An S. De & Fernando C. Fervenza. (2020). PEXIVAS. Clinical Journal of the American Society of Nephrology. 16(2). 307–309. 10 indexed citations
11.
Vriese, An S. De, Rogier Caluwé, Dirk De Bacquer, et al.. (2019). Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study. Journal of the American Society of Nephrology. 31(1). 186–196. 125 indexed citations
12.
Vriese, An S. De, Sanjeev Sethi, Karl A. Nath, Richard J. Glassock, & Fernando C. Fervenza. (2018). Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach. Journal of the American Society of Nephrology. 29(3). 759–774. 172 indexed citations
13.
Caluwé, Rogier, An S. De Vriese, Bruno Van Vlem, & Francis Verbeke. (2018). Measurement of pulse wave velocity, augmentation index, and central pulse pressure in atrial fibrillation: a proof of concept study. Journal of the American Society of Hypertension. 12(8). 627–632. 10 indexed citations
14.
Bonjour, J.-P. & An S. De Vriese. (2010). IOF World Congress on Osteoporosis & 10th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. Osteoporosis International. 21(S1). 389–400. 1 indexed citations
15.
Vriese, An S. De, Francis Verbeke, Olivier Winter, et al.. (2009). Comparison of the prognostic value of dipyridamole and dobutamine myocardial perfusion scintigraphy in hemodialysis patients. Kidney International. 76(4). 428–436. 7 indexed citations
16.
Selleslag, Dominik, Johan R. Boelaert, E Matthys, et al.. (2005). MANAGEMENT OF THERAPY-RESISTANT SYSTEMIC LUPUS ERYTHEMATOSUS WITH RITUXIMAB: REPORT OF A CASE AND REVIEW OF THE LITERATURE. Acta Clinica Belgica. 60(2). 102–105. 9 indexed citations
17.
Taes, Youri, Birgitte Wuyts, Johan R. Boelaert, An S. De Vriese, & Joris Delanghe. (2004). Prohepcidin accumulates in renal insufficiency. Clinical Chemistry and Laboratory Medicine (CCLM). 42(4). 387–9. 78 indexed citations
18.
Vriese, An S. De, Henk J. Blom, Leo A. J. Kluijtmans, et al.. (2002). Early molecular events in the development of the diabetic cardiomyopathy. Amino Acids. 23(1-3). 331–336. 53 indexed citations
19.
Vriese, An S. De, Dirk Vogelaers, & Norbert Lameire. (1997). Sepsis and acute renal failure.. Ghent University Academic Bibliography (Ghent University).
20.
Vriese, An S. De, et al.. (1995). Carbamazepine Hypersensitivity Syndrome: Report of 4 Cases and Review of the Literature. Medicine. 74(3). 144–151. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026